Clinical Trial Update: Study of DS-1001b in Patients With Gene IDH1-Mutated Gliomas [Phase 1]

View source ↗

Summary

A Phase 1 study of DS-1001b in patients with IDH1-mutated gliomas is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioma
• Isocitrate Dehydrogenase 1-mutant Glioma

Drugs mentioned

• DS-1001b

Snippet

Sponsor: Daiichi Sankyo | Conditions: Glioma | Phase 1 | Status: ACTIVE_NOT_RECRUITING